Tumour necrosis factor receptor 1 and mortality in a multi-ethnic cohort: The northern manhattan study

Age and Ageing

Volumn 42, Issue 3, 2013, Pages 385-390

  Luna, Jorge M ^a   Moon, Yeseon ^a   Liu, Khin ^a   Spitalnik, Steven ^a   Paik, Myunghee ^a   Sacco, Ralph ^b   Elkind, Mitchell S V ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol use; Inflammation; Insurance status; Mortality risk; Older people

Indexed keywords

SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; URBAN POPULATION; VASCULAR DISEASE;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BIOLOGICAL MARKERS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HISPANIC AMERICANS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INSURANCE, HEALTH; LIKELIHOOD FUNCTIONS; MALE; MEDICAID; MIDDLE AGED; MORTALITY; NEW YORK CITY; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RISK ASSESSMENT; RISK FACTORS; SOCIAL CLASS; TIME FACTORS; UNITED STATES; URBAN HEALTH;

EID: 84877032542     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afs175     Document Type: Article

References (15)

1. Yu M, Lam J, Rada B, Leto TL, Levine SJ. Double-stranded RNA induces shedding of the 34-kDa soluble TNFR1 from human airway epithelial cells via TLR3-TRIF-RIP1-dependent signaling: roles for dual oxidase 2- and caspase-dependent pathways. J Immunol 2011; 186: 1180-8.
2. Kapadia S, Torre-Amione G, Yokoyama T, Mann DL. Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro. Am J Physiol 1995; 268 (2 Pt 2): H517-25.
3. Mohler KM, Torrance DS, Smith CA et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993; 151: 1548-61.
4. Cope AP, Aderka D, Doherty M et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992; 35: 1160-9.
5. Heilig B, Wermann M, Gallati H et al. Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis. Clin Investig 1992; 70: 22-7.
6. Spahr L, Giostra E, Frossard JL, Bresson-Hadni S, Rubbia-Brandt L, Hadengue A. Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis. J Hepatol 2004; 41: 229-34.
7. Pilz G, Fraunberger P, Appel R et al. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations. Crit Care Med 1996; 24: 596-600.
8. Parsons PE, Matthay MA, Ware LB, Eisner MD. Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005; 288: L426-31.
9. Fujikawa K, Kawakami A, Eguchi K. Etanercept: recombinant human soluble tumor necrosis factor receptor fusion protein. Nippon Rinsho 2007; 65: 1211-7.
10. Elkind MS, Cheng J, Boden-Albala B et al. Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke 2002; 33: 31-7.
11. Takei Y, Di Tullio MR, Homma S et al. Soluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy: the Northern Manhattan Study. Am J Hypertens 2009; 22: 763-9.
12. Elkind MSV, Luna JM, Moon YP et al. High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study. Neurology 2009; 73: 1300-7.
13. Diniz BS, Teixeira AL, Ojopi EB et al. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis 2010; 22: 1305-11.
14. Scalzo P, Kummer A, Cardoso F, Teixeira AL. Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease. J Neuroimmunol 2009; 216: 122-5.
15. Kaminska J, Nowacki MP, Kowalska M et al. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor